Table 1 Correlation between Pygo2 expression and clinicopathological features of human glioma tissues.

From: Pygo2 functions as a prognostic factor for glioma due to its up-regulation of H3K4me3 and promotion of MLL1/MLL2 complex recruitment

Clinicopathological features

n

Pygo2

P valuea

Over expression (%)

Nomal expression (%)

Age

 ≤50 years

56

31 (55.36)

25 (44.64)

0.001*

 >50 years

153

121 (79.08)

32 (20.92)

Gender

 Male

137

102 (74.45)

35 (25.55)

0.440

 Female

72

50 (69.44)

22 (30.56)

Astrocytoma

 Anaplastic astrocytoma

63

46 (73.02)

17 (26.98)

0.984

 Diffuse astrocytoma

65

49 (75.38)

16 (24.62)

 Yellow astrocytoma

4

3 (75.00)

1 (25.00)

WHO phase

 I

26

11 (42.31)

15 (57.69)

0.000*

 II

77

46 (59.74)

31 (40.26)

 III

59

48 (81.36)

11 (18.64)

 IV

47

44 (93.62)

3 (6.38)

  1. aStatistical significance was determined using Fisher’s exact test.
  2. *Significant relation of clinicopathological features with glioma.
Back to article page